Stocks Alert: Halozyme Therapeutics, Inc. (NASDAQ:HALO), EXACT Sciences ... Market News Call 28 announced that the European Commission (EC) has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma. Following the approval of ... |
